Next Article in Journal / Special Issue
Voltage-Gated Calcium Channel Antagonists and Traumatic Brain Injury
Previous Article in Journal
How “Pharmacoresistant” is Cav2.3, the Major Component of Voltage-Gated R-type Ca2+ Channels?
Previous Article in Special Issue
Calcium Channel Blockers as Tocolytics: Principles of Their Actions, Adverse Effects and Therapeutic Combinations
 
 
Brief Report

Article Versions Notes

Pharmaceuticals 2013, 6(6), 777-787; https://doi.org/10.3390/ph6060777
Action Date Notes Link
article pdf uploaded. 29 May 2013 15:39 CEST Version of Record https://www.mdpi.com/1424-8247/6/6/777/pdf
article xml file uploaded 13 September 2013 17:19 CEST Original file https://www.mdpi.com/1424-8247/6/6/777/xml
article html file updated 13 September 2013 17:19 CEST Original file -
article html file updated 17 June 2015 09:49 CEST Update -
article html file updated 20 March 2019 23:11 CET Update -
article html file updated 8 May 2019 04:34 CEST Update -
article html file updated 6 February 2020 02:23 CET Update https://www.mdpi.com/1424-8247/6/6/777/html
Back to TopTop